1. Volume 25, Issue 1, Pages 6-12 (January 2015)
Understanding Disparities in Lipid Management Among Patients with Type 2 Diabetes: Gender Differences in Medication Nonadherence after Treatment Intensification 
John Billimek, PhD, Shaista Malik, MD, PhD, Dara H. Sorkin, PhD, Priel Schmalbach, PhD, Quyen Ngo-Metzger, MD, MPH, Sheldon Greenfield, MD, Sherrie H. Kaplan, PhD, MPH 
Women's Health Issues 
Volume 25, Issue 1, Pages 6-12 (January 2015)
DOI: /j.whi
Copyright © 2015 Jacobs Institute of Women's Health Terms and Conditions

2. Figure 1
Comparing the association of treatment intensification with patient-reported cost-related nonadherence and nonadherence related to side effects of the medication across genders. After adjustment for age, education, race/ethnicity, and insurance status, the test for gender by regimen intensification interaction is significant for nonadherence related to side effects (p = .048). Error bars represent 95% CIs.
Women's Health Issues  , 6-12DOI: ( /j.whi )
Copyright © 2015 Jacobs Institute of Women's Health Terms and Conditions